Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

February 11, 2026 7:45 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that it has entered into a securities purchase agreement on February 6, 2026 (the "Securities Purchase Agreement") with select institutional and accredited investors (collectively, the "Investors") for the purchase and sale of up to 26,250 shares of Series A...

Read more

Black Book Research Releases "Brazil Acute Care EHR and Digital Health 2026" Report Highlighting RNDS Interoperability, AI Governance Readiness, and Cyber-Resilient Hospital Modernization

February 11, 2026 7:30 AM

Black Book Market Research today announced the release of its new qualitative market report, "Brazil Acute Care EHR and Digital Health 2026: Demand Drivers, National Platforms, Standards, and Vendor Landscape." The report details how Brazil's acute-care providers and hospital groups are recalibrating EHR and digital hospital investments for the 2026-2030 planning horizon as national interoperability expectations accelerate and operational...

Read more

Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion

February 11, 2026 7:00 AM

Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence ('AI') platform EinsteinRx™into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that it has expanded its partnership Tollo Health, LLC ('Tollo Health'). The partnership expansion includes the addition of telehealth services being developed by...

Read more

Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award

February 11, 2026 7:00 AM

The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), along with the American Heart Association (Heart Association), and EveryGrant® implemented by Conquer Cancer®, the ASCO Foundation (Conquer Cancer), with funding from the Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization, recently announced the third cohort of physicians selected to receive the prestigious Winn Clinical...

Read more

Genflow Biosciences PLC Announces Notice of GM

February 11, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a European-based biotechnology company focused on the development of gene therapies for age-related diseases, announces that the Board is considering potentially undertaking an equity raise which would be structured by issuing rights over the New Shares (in the form of shares or warrants) to new investors and/or existing shareholders in the Company for cash...

Read more

Medicare Part B is Not a Plan B

February 10, 2026 8:50 PM

Studies consistently show that most long-term residents in skilled nursing facilities rely on Medicaid to assist with the cost of long-term care. With the transition to a Patient-Driven Payment Model (PDPM) for Medicaid reimbursement, states now have discretion in determining which PDPM components are included in their reimbursement model.Of the five PDPM components, Nursing, Physical Therapy (PT), Occupational Therapy (OT), Speech-Language...

Read more

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

February 10, 2026 6:00 PM

Moderna, Inc. (NASDAQ:MRNA) today announced the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has notified the Company that it will not initiate a review of the biologics license application (BLA) for its investigational influenza vaccine, mRNA-1010, and has issued a Refusal-to-File (RTF) letter. Moderna had exercised a Priority Review Voucher to facilitate a timely review of the application.CBER's...

Read more

Dr. Bedri Yusuf Calls for System-Level Action to Address the Physician Workforce Crisis

February 10, 2026 4:15 PM

Dr. Bedri Yusuf, an experienced physician executive and board-certified internal medicine physician, is raising awareness about the growing physician workforce shortage and the urgent need for healthcare systems to change how they support doctors and care teams.After more than 25 years in clinical practice and senior leadership roles, Dr. Yusuf says the issue is no longer theoretical. It is already affecting patient access, quality of care, and...

Read more

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

February 10, 2026 4:10 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced financial results for its third fiscal quarter and nine months ended December 31, 2025."Sonoma is pleased to report another quarter of revenue...

Read more

Jorie AI Shares a Live Case Study on the Inevitable Future of Healthcare AI at ViVE 2026

February 10, 2026 12:50 PM

Jorie AI, a leader in healthcare revenue cycle automation, announced its presence at ViVE 2026, where the company will bring live case studies, executive conversations, and real-world demonstrations of autonomous healthcare AI to the show floor at Booth #1402.At ViVE 2026, Jorie AI will center its presence around a defining message for the industry: autonomous healthcare AI is inevitable-but only when it can execute across real healthcare...

Read more

Leading Board-Certified Plastic Surgeon Dr. David W. Allison Moves to New Princeton Location on Bunn Drive

February 10, 2026 12:00 PM

Board-certified plastic surgeon David W. Allison, MD has relocated his practice to Princeton, New Jersey, now seeing patients at 256 Bunn Drive, Suite A1, as part of the Becker Plastic Surgery network. The move reflects a continued commitment to providing comprehensive cosmetic and reconstructive plastic surgery care in a convenient Central New Jersey setting.Dr. Allison brings more than 23 years of surgical experience and has performed over...

Read more

CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity

February 10, 2026 11:45 AM

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce that it has raised £2,500,000 from a consortium of private investors through a direct subscription for 333,333 new ordinary shares in the Company at a price of £7.50 per share. The new investors will also receive a three year warrant to subscribe on a one-for-one basis for ordinary shares in the Company at £9 per share. Some of these...

Read more

MDCE Turns $1M Asset Portfolio Into Strategic Capital for AI Development (OTC PINK:MDCE)

February 10, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced it is executing a non-dilutive funding strategy supported by tangible, high-value assets held by its wholly owned subsidiary, Infinite Auctions, which currently maintains an estimated market value approaching $1 million in sports cards and elite game-worn memorabilia. This is exciting news with the pending release of the company's first AI based mobile application.As part of this...

Read more

TRNR Files Lawsuits Against Sportstech and Ali Ahmad and Announces March 11, 2026 Public Auction of All Shares of Sportstech

February 10, 2026 9:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) (the "Company") today announced that it has filed two distinct lawsuits in connection with the previously disclosed defaulted loan to Sportstech Brands Holding GmbH ("Sportstech"), and the corresponding personal guarantee by Ali Ahmad. The Company further announced that a public auction of 100% of the shares in Sportstech pledged to Interactive Strength will be conducted on March 11, 2026, at 11:00 a.m....

Read more

Change of Date for Publication of the Interim Report January-March 2026

February 10, 2026 9:15 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO Perfusion AB (publ) has decided to postpone the publication of its interim report for the period January-March 2026. The interim report will be published on Friday, 24 April 2026, instead of the previously communicated date of Wednesday, 22 April 2026.The change is due to the fact that the previously announced reporting date coincides with the presentation of XVIVO's U.S. heart preservation...

Read more

NCQA Kicks Off Inaugural Learning Collaborative to Measure Patient Engagement

February 10, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) officially launched its Measuring Patient Engagement Learning Collaborative as part of a series designed to explore how healthcare organizations should assess, manage and deliver digitally-enabled interventions to support effective condition management and well-being. NCQA is convening 13 organizations from across the health ecosystem, representing health plans, vendors, clinicians and...

Read more

Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides

February 10, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has filed an application for "Orphan Drug Designation" (ODD) for NV-387 as a Treatment for Measles with the US FDA Office of Orphan Products Development (OOPD).If approved,...

Read more

Best Mushroom Extract Supplements in 2026: How Formulations Are Evaluated

February 10, 2026 8:20 AM

What Mushroom Extract Supplements Are and Why People Use Them in 2026Mushroom extract supplements have firmly moved from a niche wellness trend into a mainstream category by 2026.What was once associated mostly with alternative nutrition or experimental routines is now part of everyday supplement stacks for many people. The reason is simple: mushroom extracts are no longer marketed as exotic solutions, but as practical, routine-friendly...

Read more

DirectTrust(R) Reports Record High Exchange Activity in 2025, With Nearly 1.9 Billion Direct Exchange Transactions

February 10, 2026 8:00 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, today announced full-year 2025 metrics from its accredited Health Information Service Provider (HISP) members, highlighting record-high Direct exchange activity in 2025 and continued growth in the use of the DirectTrust national network for secure, interoperable...

Read more

Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 10, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that it has received formal notice from the Listings Qualifications staff of The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The Company...

Read more